Revenue Update on WaferGen Bio-systems(NASDAQ:WGBS)

WaferGen Bio-systems(NASDAQ:WGBS) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Aug 9, 2016. Company reported revenue of $2.52M. Analysts estimated a revenue of $2.60M. Earnings per share were $-0.26. Analysts had estimated an EPS of $-0.18.

WaferGen Bio-systems (WGBS) shares turned negative on Wednesdays trading session with the shares closing down -0.006 points or -0.71% at a volume of 3,14,459. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $0.85. The peak price level was also seen at $0.85 while the days lowest was $0.811. Finally the shares closed at $0.836. The 52-week high of the shares is $3.47 while the 52-week low is $0.455. According to the latest information available, the market cap of the company is $16 M.

Several Insider Transactions has been reported to the SEC. On Oct 21, 2015, Rolland Carlson (CEO) purchased 200,000 shares at $0.00 per share price.Also, On Sep 25, 2015, Investment Company, Inc. Awm (10% owner) sold 505,282 shares at $2.08 per share price.

WaferGen Bio-systems Inc. is engaged in the development of systems for gene expression quantification genotyping and stem cell research. The Company is focused on the development manufacture and marketing of its SmartChip System a genetic analysis platform used for profiling and validating molecular biomarkers in the life sciences and pharmaceutical drug discovery industries. The Company’s SmartChip System provides a range of capabilities including messenger ribonucleic acid microRNA and long non-coding ribonucleic acid (RNA) expression level measurement as well as single nucleotide polymorphism genotyping. The Company’s products include Gene Expression Technology SmartChip Target Enrichment (TE) System and Apollo 324 Library Preparation. It has launched its first generation SmartChip 5K System which is a real-time polymerase chain reaction tool. It has launched the SmartChip MyDesign System which is the second-generation instrument with upgraded capabilities.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

WaferGen Bio-systems - Is it time to Sell?

Top Brokerage Firms are advising their investors on WaferGen Bio-systems. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.